Minnesota Health Department Seeks Public Input on JUUL Settlement

Regulations by 2FIRSTS.ai

Feb.19.2024

Minnesota Health Department Seeks Public Input on JUUL Settlement

Minnesota Health Department seeks public input on $60.5M JUUL settlement for nicotine prevention and cessation efforts.

Last May, Minnesota Attorney General Keith Ellison announced a $60.5 million settlement agreement with JUUL Labs over deceptive marketing of e-cigarettes. Now, the Minnesota Department of Health is seeking public input on how to use this money.

Parker Smith from the state health department stated, "The purpose of these opinion surveys is to truly engage with the community, understand what solutions community members would like to see. There is no one-size-fits-all solution. Therefore, it is important for us to listen to the public, understand their realities, and tailor our ongoing efforts in prevention and smoking cessation according to their needs." He also mentioned that a portion of the funding will be used to repay legal fees.

In the past, we have collaborated with the community to gather opinions on various strategies and business tobacco prevention and control initiatives. But with this funding, we have the opportunity to do some new things, some innovative things for nicotine control.

The next public consultation will be held at the St. Claude River District Library this Wednesday, February 21st, from 2:00 to 3:30 in the afternoon.

Also Read:

[1] North Carolina Attorney General Launches JUUL Lawsuit Public Database

[2] Juul's Controversial Partnership with Reverend Al Sharpton Raises Concerns

[3] Washington Schools Installing E-Cigarette Alarms to Deter Student Usage

#North America #United States #Open system e-cigarettes #Regulation #Health #Public opinion.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours

The U.S. FDA has added six ON!® PLUS nicotine pouch products to its list of Marketing Granted Order (MGO) authorizations. Based on 2Firsts’ review, the approved products feature a highly standardized configuration in terms of format, nicotine strength, and flavour portfolio, primarily focusing on 6 mg and 9 mg strengths and traditional variants such as mint, wintergreen, and tobacco—reflecting a clear compliance-oriented approach.

Dec.22 by 2FIRSTS.ai

Wales Passes Law Banning Tobacco Sales to Anyone Born After 2009

The Welsh Parliament (Senedd) has approved new legislation banning tobacco sales to anyone born on or after January 1, 2009. The law, passed on December 9, 2025, also imposes stricter controls on how vapes and nicotine products are advertised and sold. Designed by the UK Government but voted on separately in Wales, the bill passed with 36 votes in favor, two abstentions, and nine against. It grants stronger enforcement powers to Trading Standards to combat illegal tobacco and vape sales.

Dec.10 by 2FIRSTS.ai

Morocco Lawmakers Propose Excise Taxes on Vapes, Hookah, and Nicotine Alternatives

Members of the Socialist Union of Popular Forces (USFP) have submitted amendments to Article 7 of the Finance Bill, introducing new excise taxes on e-cigarette liquids, hookah accessories, and non-tobacco nicotine products. The proposal also revises VAT exemptions and insurance tax rates to enhance fiscal fairness and revenue clarity.

Nov.11 by 2FIRSTS.ai

ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting

The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.